CELZ - Creative Medical Technology Holdings Inc

NYSE * Health Care * Biotechnology

$2.47

+$0.14 (+6.01%)

About Creative Medical Technology Holdings Inc

Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction, and FemCelz for the treatment of loss of genital sensitivity and dryness. It develops AlloStem (CELZ-201-DDT), a allogenic human perinatal tissue derived cell program, ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, which is phase 2, for the treatment of type 1 diabetes; AlloStemSpine (CELZ 201 ADAPT), which is phase 2, for the treatment of chronic lower back pain; Alova, a platform to treat infertility as a result of premature ovarian failure; StemSpine, a regenerative stem cell procedure to treat degenerative disc disease; OvaStem, a stem cell therapy for premature ovarian failure; CaverStem for erectile dysfunction treatment; and FemCelz for female sexual function treatment. In addition, the company develops products and services for various indications, including preventing the rejection of transplanted organs, kidney failure, liver failure, heart attack, and Parkinson's disease. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.

CELZ Key Statistics

Market Cap

$8.61M

0

P/B Ratio

1.14

EPS

$-2.52

Employees

4

How CELZ Compares to Peers

CELZ is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

N/A

of 5

Size Rank

#6

of 6

CompanyP/EGrowthCompare
CELZN/A0%-
AMGN24.60%vs AMGN
GILD20.40%vs GILD
VRTX28.40%vs VRTX
REGN18.00%vs REGN
BIIB20.0-0%vs BIIB

Creative Medical Technology Holdings Inc Company Information

Headquarters
Arizona; U.S.A
Website
www.creativemedicaltechnology.com
Sector
Health Care
Industry
Biotechnology
Data Updated:
Ready to invest in CELZ?

Commission-free trading available. Affiliate links.

CELZ Lician Score

10% confidence
4.0/10
Neutral

CELZ has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

1.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates CELZacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

CELZ Financial Snowflake

5-axis analysis across key investment dimensions

4.2/10

Neutral

35810Value5.0Growth1.0Quality5.0Momentum5.0Safety5.04.2/10
5.0

Value

1.0

Growth

5.0

Quality

5.0

Momentum

5.0

Safety

Upcoming Events for CELZ